Using this approach, Keats et al. were able to show that the most aggressive Vk*MYC clones engrafted more rapidly in congenic wild type mice, were also able to engraft in Vk*MYC tumor bearing mice, and were able to completely replace the pre-existing MM clone. Here, MYC is linked to Miyoshi myopathy.